We found that growth arrest-specific protein 6 (GAS6), the high-affinity ligand of AXL, was significantly upregulated in the supernatant from reactive astrocytes (Figure 6B) and the CSF samples of NSCLC BrM patients (Figure 6C, Table S3). The gene discussed is AXL; the disease is non-small cell lung carcinoma.